About this trial
This clinical trial studies statewide optimization of lung cancer screening (LCS) in Kentucky using the Quality Implementation of Lung Screening (QUILS™) System. Data from the Kentucky Cancer Registry shows that LCS implementation has contributed to a rapid decline in late-stage lung cancer diagnosis at twice the national average. Further, the declines are more than three times the national average decline in Kentucky's Central Appalachian region. Kentucky-based multilevel initiatives are needed to expand and accelerate this leading role and extend the LCS opportunity to more Kentuckians who are at increased risk of lung cancer. This trial may be able to accelerate optimal high-quality implementation of LCS utilizing the QUILS™ System and reduce the burden of lung cancer by assisting lung cancer screening programs located throughout Kentucky in implementing best practices in lung cancer screening by integrating the QUILS™ System domains and elements into their screening programs.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Member of a participating Lung Cancer Screening Program (LCSP) team or administrator
Willing to participate in the QUILS Index Assessment Survey process
Willing to participate in the QUILS Audit Feedback presentations
Willing to participate in formative evaluation interviews
Disqualifiers
Unwilling to participate in the QUILS Index Assessment Survey process
Unwilling to participate in the QUILS Audit Feedback presentations
Unwilling to participate in formative evaluation interviews
Trial design
Single group
Treatments tested in this trial
Quality Implementation of Lung Cancer Screening (QUILS) System
BehavioralThe QUILS System is a health services research intervention designed to improve the quality of lung cancer screening programs. The intervention includes QUILS Index Assessment, QUILS Audit and Feedback Report and Presentation, QUILS Resource Portal, site-specific action plans, and formative evaluation activities.
Treatment groups
Trial outcomes
Primary outcomes
Change in Quality Improvement Lung Cancer Screening (QUILS) Index Assessment Score
The QUILS Index Assessment is a program-level measure of lung cancer screening implementation quality. Scores range from 0 to 95, with a higher score indicating higher quality implementation of lung cancer screening practices. The outcome measure is the change in total QUILS Index score from Baseline to 12 months.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Timothy Mullett
Lead sponsor
University of Kentucky
Sponsor institution